Iron-bioavailable tef grain varieties for combating iron deficiency anemia

Overview

Iron deficiency anemia affects nearly 2.3 billion people globally, making it one of the most pressing public health challenges. This research focuses on tef (Eragrostis tef), an ancient grain crop from Ethiopia that contains significantly more bioavailable iron than major cereals such as wheat, maize, and rice. The project aims to identify superior tef varieties with enhanced iron content and bioavailability, uncover the molecular mechanisms regulating iron uptake and accumulation, and translate these findings into biofortification strategies for staple crops.

Technical specifications

• Mineral profiling of 41 tef accessions, wheat, maize, and rice using ICP-MS (Inductively Coupled Plasma Mass Spectrometry) revealed that tef grains contain significantly higher levels of key minerals compared to major cereals.
• Iron bioavailability assay using a physiologically relevant Caco-2 cell model, which measures intracellular ferritin formation as a marker of iron uptake, demonstrated higher iron uptake from tef compared to wheat or rice, with variation among tef accessions.
• Synchrotron X-ray fluorescence microscopy revealed a strong correlation between seed iron content and its bioavailability in human cells, providing a mechanistic link between mineral content and nutritional impact.
• Planned screening of approximately 270 tef accessions from the USDA-ARS National Plant Germplasm System for mineral content, followed by bioavailability testing and transcriptome analysis (RNA-sequencing) of high and low iron accumulators in roots, flag-leaf, and inflorescence tissues to identify candidate genes regulating iron transport.
• Expected outcomes include identification of novel iron transport mechanisms applicable to biofortification of major cereals, extending the nutritional benefits beyond tef to globally consumed staple crops.

Technology readiness level

The research is at an advanced stage, with mineral content and iron bioavailability already validated across multiple tef accessions using established analytical methods (ICP-MS, Caco-2 cell models, and synchrotron X-ray fluorescence microscopy). Future validation plans include scaling the diversity panel to approximately 270 accessions, performing transcriptome analysis to identify candidate iron transport genes, and pursuing biofortification applications. The technology readiness level is currently in the research-to-development transition phase, with strong potential for translational applications in crop improvement and nutritional intervention programs targeting iron deficiency anemia.